ALL >> Business >> View Article
All About Hemodialysis Catheters Infection Prevention

The emerging drugs Hemodialysis Catheters competitive landscape does not represent a particularly promising picture due to the lack of late-stage clinical products, which is quite evidently based on the scarcity of clinical trials being conducted. Current treatment aims to reduce symptoms and therapies targeting complications and comorbidities associated with chronic hemodialysis are the need of the hour.
Contact Activation Inhibitor and Factor XI Antibody, AB023, is being developed by Aronora. AB023 blocks factor XIIa-mediated FXI activation without inhibiting FXI activation by thrombin or the procoagulant function of FXIa. Consequently, AB023 not only adds to the armamentarium of inhibitors that target clotting factors upstream to thrombin and FXa but also provides a means of determining whether FXIIa solely drives clotting on blood-contacting medical devices or extracorporeal circuits. AB023 has completed phase II study in 2019 and there have been no further updates.
Hemodialysis Catheters Drugs
Another Aronora drug AB002 is currently being evaluated in phase II, is a recombinant thrombin analog that ...
... generates endogenous activated protein C (APC) on intravascular surfaces in a thrombomodulin-dependent manner but does not promote thrombosis. Endogenously generated APC down regulates thrombin generation, thereby reducing pathological clot formation. During hemodialysis (HD), thrombi can form within the dialyzer filter and circuit, reducing dialyzer efficiency, and increasing blood loss. Heparin administration reduces clotting within the filter and circuit, but increases bleeding risk and is not tolerated in all patients.
In 2019 Xoma Corporation announced that it has agreed to acquire the rights to potential royalty payments and a portion of the potential milestone payments associated with five hematology assets from Aronora, Inc. Which included both AB002 and AB023.
Novartis’s CSJ137 was evaluated in a phase I study to assess the safety, tolerability, and efficacy of CSJ137 in chronic hemodialysis patients. It was hypothesized that treatment with CSJ137 might improve the level of hemoglobin in patients on chronic hemodialysis with iron-restricted anemia while reducing the need for dosing with erythropoietin and intravenous iron in these patients.
Read More- Hemodialysis Catheters Pipeline
https://www.delveinsight.com/report-store/hemodialysis-catheters-pipeline-insight-and-competitive-landscape
Add Comment
Business Articles
1. Stem-xpert At Web Summit Qatar 2025, Pursuing Innovative Solutions In Stem-as-a-serviceAuthor: stem-xpert
2. Deepseek’s Rapid Rise: Disrupting The Ai Market Amid Controversy
Author: Iconic success
3. Reimagining Customer Services With Microsoft Dynamics 365 Implementation
Author: Maria
4. Upcoming Developments In Ss Flanges: Possible Effects On Different Industries
Author: Neelam Forge India
5. Mg Hector 5 Seater Price In Chennai: A Detailed Review
Author: balaji
6. Mg Hector Ev Price In Chennai: A Comprehensive Overview
Author: balaji
7. Spring Marketing Trends: How Print And Video Can Refresh Your Brand
Author: Devin Herz
8. Auto Transport Services In South Carolina
Author: Secure Car Shipping
9. Authentication Of Australian Certificates In Canada: A Complete Guide
Author: anzilanx
10. Low Maintenance Plants For Home Landscaping
Author: Apunga Landscapes
11. The Ultimate Guide To Rocking Chairs – Comfort, Style, And Elegance
Author: tushar
12. Bioethanol Market Size Insights Forecast 2024-2030
Author: Nilam Jadhav
13. Touffy Fabric Upholstered Rocking Chair – The Perfect Blend Of Comfort And Elegance
Author: tushar
14. Maximizing Efficiency: Why Small Businesses Should Outsource Bookkeeping And Financial Services
Author: KMK Ventures Pvt Ltd
15. Big Patient Data And The Future Of Real World Evidence: Learnings From Biotechx 2024
Author: Industry Chronicle